Estimating the Impact of Delayed Access to Oncology Drugs on Patient Outcomes in Canada.
Vanderpuye-Orgle J, Erim D, Qian Y, Boyne DJ, Cheung WY, Bebb G, Shah A, Pericleous L, Maruszczak M, Brenner DR.
Vanderpuye-Orgle J, et al. Among authors: brenner dr.
Oncol Ther. 2022 Jun;10(1):195-210. doi: 10.1007/s40487-022-00187-3. Epub 2022 Mar 1.
Oncol Ther. 2022.
PMID: 35230672
Free PMC article.